A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine

A successful severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine must not only be safe and protective, but must also meet the demand on a global scale at a low cost. Using the current influenza virus vaccine production capacity to manufacture an egg-based inactivated Newcastle disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Weina, McCroskery, Stephen, Liu, Wen-Chun, Leist, Sarah R., Liu, Yonghong, Albrecht, Randy A., Slamanig, Stefan, Oliva, Justine, Amanat, Fatima, Schäfer, Alexandra, Dinnon, Kenneth H., Innis, Bruce L., García-Sastre, Adolfo, Krammer, Florian, Baric, Ralph S., Palese, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766959/
https://www.ncbi.nlm.nih.gov/pubmed/33348607
http://dx.doi.org/10.3390/vaccines8040771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766959/
https://www.ncbi.nlm.nih.gov/pubmed/33348607
http://dx.doi.org/10.3390/vaccines8040771

Ejemplares similares